Compare PDYNW & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDYNW | MDAIW |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2020 | 2021 |
| Metric | PDYNW | MDAIW |
|---|---|---|
| Price | $0.01 | $0.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 89.0K | 5.7K |
| Earning Date | 02-28-2025 | 02-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.86 | 65.88 |
| EPS | N/A | ★ N/A |
| Revenue | $5,246,000.00 | ★ $19,650,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.00 | $0.36 |
| 52 Week High | $0.29 | $1.01 |
| Indicator | PDYNW | MDAIW |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 48.82 |
| Support Level | $0.01 | $0.38 |
| Resistance Level | $0.03 | $0.62 |
| Average True Range (ATR) | 0.00 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 17.99 | 46.70 |
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.